Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
AAPS PharmSciTech ; 18(3): 867-874, 2017 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-27363416

RESUMO

Irinotecan (CPT-11) is used to treat advanced colorectal cancer as an intravenous therapy. Depending on pH, CPT-11 exists in either a lactone (active) or carboxylate (inactive) form, or both. In this investigation, the feasibility for systemic delivery of CPT-11 through the buccal route was evaluated. Permeation of CPT-11 across porcine buccal mucosa was studied in vitro using side-by-side flow through diffusion cells at 37°C. Experiments were performed over a pH range from 4 to 9, and the permeability of both the lactone and carboxylate forms of CPT-11 was measured. CPT-11 steady state flux was determined over a range of donor concentrations at pH 4 (0.5, 1, 5, 10, 15, 20 mg/ml) and pH 6.8 (0.5, 5, 10 mg/ml). Steady state flux increased linearly with increasing donor concentration of CPT-11 at pH 4 (r 2 = 0.9935) and at pH 6.8 (r 2 = 0.9886). CPT-11 permeability was independent of pH, although the distribution coefficient increased with increasing pH. Estimates of permeability for the lactone and carboxylate forms were 4.16 × 10-5 cm/s and 2.6 × 10-5 cm/s, respectively. These calculated permeability values were in agreement with the in vitro experimental data. Overall, CPT-11 was found to permeate through porcine buccal mucosa via passive diffusion. CPT-11 permeability was independent of pH, suggesting that the compound was transported mainly via a paracellular route. Overall, the results of this research suggest that the buccal route is a potential extravascular mode of delivery for CPT-11.


Assuntos
Camptotecina/análogos & derivados , Mucosa Bucal/metabolismo , Administração Bucal , Animais , Transporte Biológico/efeitos dos fármacos , Camptotecina/administração & dosagem , Camptotecina/química , Difusão , Sistemas de Liberação de Medicamentos/métodos , Concentração de Íons de Hidrogênio , Irinotecano , Permeabilidade , Suínos
2.
Am J Clin Dermatol ; 17(6): 593-600, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27734331

RESUMO

Malpractice risk is a common source of concern for the practicing physician. Dermatologists experience fewer lawsuits than most other specialists in medicine, but the risk is not negligible. All physicians should familiarize themselves with areas of potential risk and avoid medico-legal pitfalls. We present Part I of a two-part series addressing medico-legal questions common to most practitioners that cause a great deal of anxiety. Part I will focus upon risk management and prevention of future malpractice lawsuits, and Part II deals with suggestions and guidance once a lawsuit occurs. Herein, we discuss the primary sources of malpractice lawsuits delivered against healthcare practitioners including issues with informed consent, patient noncompliance, medical negligence, and inappropriate documentation, including use of electronic medical records. The overall goal is to effectively avoid these common sources of litigation. The risk management strategies discussed in this paper are relevant to the everyday practitioner and may offer physicians some degree of protection from potential liability.


Assuntos
Dermatologia/organização & administração , Consentimento Livre e Esclarecido/legislação & jurisprudência , Imperícia/legislação & jurisprudência , Erros Médicos/legislação & jurisprudência , Cooperação do Paciente , Gestão de Riscos/métodos , Dermatologia/legislação & jurisprudência , Documentação , Registros Eletrônicos de Saúde/legislação & jurisprudência , Humanos , Guias de Prática Clínica como Assunto , Telemedicina/legislação & jurisprudência , Estados Unidos
3.
Am J Clin Dermatol ; 17(6): 601-607, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27785707

RESUMO

Facing a malpractice lawsuit can be a daunting and traumatic experience for healthcare practitioners, with most clinicians naïve to the legal landscape. It is crucial for physicians to know and understand the malpractice system and his or her role once challenged with litigation. We present part II of a two-part series addressing the most common medicolegal questions that cause a great deal of anxiety. Part I focused upon risk-management strategies and prevention of malpractice lawsuits, whereas part II provides helpful suggestions and guidance for the physician who has been served with a lawsuit complaint. Herein, we address the best approach concerning what to do and what not to do after receipt of a legal claim, during the deposition, and during the trial phases. We also discuss routine concerns that may arise during the development of the case, including the personal, financial, and career implications of a malpractice lawsuit and how these can be best managed. The defense strategies discussed in this paper are not a guide separate from legal representation to winning a lawsuit, but may help physicians prepare for and cope with a medical malpractice lawsuit. This article is written from a US perspective, and therefore not all of the statements made herein will be applicable in other countries. Within the USA, medical practitioners must be familiar with their own state and local laws and should consult with their own legal counsel to obtain advice about specific questions.


Assuntos
Dermatologistas/psicologia , Dermatologia/legislação & jurisprudência , Seguro de Responsabilidade Civil , Imperícia/legislação & jurisprudência , Relações Médico-Paciente , Dermatologistas/economia , Dermatologistas/legislação & jurisprudência , Documentação , Humanos , Relações Interprofissionais , National Practitioner Data Bank , Guias de Prática Clínica como Assunto , Relações Profissional-Família , Estados Unidos
4.
J Contemp Dent Pract ; 17(5): 408-13, 2016 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-27443368

RESUMO

BACKGROUND: Some relation exists between oral and general health with progressive aging. Certain risk factors are common between oral and systemic diseases. Absence of teeth also affects the oral health by altering the quality of life. Hence, the nutritional changes occurring in elderly patients following prosthodontic rehabilitation are evaluated. MATERIALS AND METHODS: A total of 250 patients who underwent prosthodontic treatment for missing teeth were included for the study. Twice measurement of nutritional parameters was done: Initially at the time of diagnosis and then 5 months following commencement of the prosthodontic treatment. Dental analysis, evaluation of the diet, anthropometric assessment, and analysis of serum biochemical values were done in all the patients and tabulated records were maintained. Independent Student's t test and Tukey's test were done to assess the level of significance. RESULTS: A total of 250 patients were included for the study. The complete denture (CD) group showed the highest alteration in the mean values of the nutritional parameters followed by the removable partial denture group. A significant change was seen in the body mass index, protein, carbohydrate, and iron levels among the different patients who were grouped based on the mode of treatment modality. The CD group showed significantly higher mean change in carbohydrates value compared with mean change in patients receiving fixed treatment. CONCLUSION: Both nutrition and diet form an integral part of the prosthodontic treatment to maintain the health of elderly population. CLINICAL SIGNIFICANCE: With the advancement in the level of edentulism, rehabilitation by prosthetic treatment has become progressively important to restore and improve dietary parameters.


Assuntos
Arcada Edêntula , Estado Nutricional , Prostodontia , Qualidade de Vida , Idoso , Prótese Total , Prótese Parcial Fixa , Prótese Parcial Removível , Feminino , Avaliação Geriátrica , Nível de Saúde , Humanos , Arcada Edêntula/reabilitação , Arcada Parcialmente Edêntula/reabilitação , Masculino , Mastigação , Saúde Bucal , Perda de Dente
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA